Clinical Trial Update: Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on BNC210 for acute, as-needed treatment of anxiety in Social Anxiety Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• BNC210

Snippet

Sponsor: Bionomics Limited | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED